Stockscreener 앱 받기
4.60
5.35%
-0.26
시간 외 거래:
4.50
-0.10
-2.17%
전일 마감가:
$4.86
열려 있는:
$4.8
하루 거래량:
2.00M
Relative Volume:
0.63
시가총액:
$524.00M
수익:
$1.08M
순이익/손실:
$-106.26M
주가수익비율:
-3.1539
EPS:
-1.4585
순현금흐름:
$-106.85M
1주 성능:
-9.98%
1개월 성능:
-18.58%
6개월 성능:
+44.20%
1년 성능:
+94.92%
1일 변동 폭
$4.37
$4.92
1주일 범위
$4.37
$5.385
52주 변동 폭
$1.60
$6.16
Perspective Therapeutics Inc Stock (CATX) Company Profile
명칭
Perspective Therapeutics Inc
전화
509-375-1202
주소
350 Hills Street, Suite 106, Richland
Compare CATX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
4.60 | 553.62M | 1.08M | -106.26M | -106.85M | -1.4585 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 개시 | Piper Sandler | Overweight |
| 2025-11-24 | 재개 | Truist | Buy |
| 2025-10-10 | 개시 | BTIG Research | Buy |
| 2025-03-13 | 개시 | H.C. Wainwright | Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-11-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-10-01 | 개시 | Wedbush | Outperform |
| 2024-09-25 | 개시 | Truist | Buy |
| 2024-07-25 | 개시 | BofA Securities | Buy |
| 2024-05-09 | 개시 | Cantor Fitzgerald | Overweight |
모두보기
Perspective Therapeutics Inc 주식(CATX)의 최신 뉴스
Perspective Therapeutics Q1 EPS Boosted by Brookline Cap M - MarketBeat
Jones Trading reiterates Perspective Therapeutics stock Buy rating By Investing.com - Investing.com India
Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX) - The Globe and Mail
Jones Trading reiterates Perspective Therapeutics stock Buy rating - Investing.com
Perspective Therapeutics (CATX) Receives Analyst Rating Boost | CATX Stock News - GuruFocus
B. Riley Financial Issues Positive Forecast for Perspective Therapeutics (NYSEAMERICAN:CATX) Stock Price - MarketBeat
Perspective Therapeutics (CATX) Receives Analyst Rating Boost | - GuruFocus
Perspective Therapeutics (CATX) Receives Boost from UBS with Rai - GuruFocus
Perspective Therapeutics price target raised to $13 from $11 at B. Riley - TipRanks
UBS Adjusts Price Target on Perspective Therapeutics to $8 From $7, Maintains Buy Rating - marketscreener.com
UBS Group Forecasts Strong Price Appreciation for Perspective Therapeutics (NYSEAMERICAN:CATX) Stock - MarketBeat
Perspective Therapeutics (CATX) Rating Reiterated by Wedbush | C - GuruFocus
Perspective Therapeutics (NYSEAMERICAN:CATX) Receives Outperform Rating from Wedbush - MarketBeat
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and IDEAYA Biosciences (IDYA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT) - The Globe and Mail
B. Riley Raises Price Target on Perspective Therapeutics to $13 From $11, Keeps Buy Rating - marketscreener.com
Perspective Therapeutics (CATX) to Release Earnings on Wednesday - MarketBeat
RBC cuts Perspective Therapeutics stock price target on model updates By Investing.com - Investing.com Australia
Perspective Therapeutics Q4 2025 earnings preview - MSN
Perspective Therapeutics to share tumor therapy data at 2026 cancer meeting - Stock Titan
Truist reiterates Buy on Perspective Therapeutics stock By Investing.com - Investing.com Canada
BTIG Reiterates Buy Rating for CATX with $14 Price Target | CATX Stock News - GuruFocus
Royal Bank Of Canada Lowers Perspective Therapeutics (NYSEAMERICAN:CATX) Price Target to $14.00 - MarketBeat
RBC Capital Lowers Price Target for CATX While Maintaining 'Outp - GuruFocus
Truist reiterates Buy on Perspective Therapeutics stock - Investing.com
RBC cuts Perspective Therapeutics stock price target on model updates - Investing.com
Oppenheimer reiterates Perspective Therapeutics stock rating at Outperform By Investing.com - Investing.com South Africa
Perspective Therapeutics stock rating reiterated at Buy by BTIG - Investing.com India
Oppenheimer reiterates Perspective Therapeutics stock rating at Outperform - Investing.com
Perspective Therapeutics (NYSEAMERICAN:CATX) Receives "Buy" Rating from BTIG Research - MarketBeat
Perspective Therapeutics, Inc. 2025 10-K Report: Advancing Targeted Alpha Therapy Radiopharmaceuticals for Cancer Treatment - Minichart
Perspective Therapeutics (NYSEAMERICAN:CATX) Stock Price Up 4.4%Here's What Happened - MarketBeat
Perspective Therapeutics Reports 2025 Results, Highlights Pipeline Progress - TipRanks
Perspective Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Perspective Therapeutics (NYSE: CATX) expands targeted alpha cancer pipeline - Stock Titan
CATX: Clinical pipeline advances with strong safety, efficacy, and funding to support growth into 2027 - TradingView
Perspective Therapeutics (NYSE: CATX) details 2025 loss and cash runway to 2027 - Stock Titan
BRIEF-Perspective Therapeutics FY EPS USD -1.4 - TradingView
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results - GlobeNewswire
Perspective Therapeutics (CATX) Set to Release Q4 Earnings - GuruFocus
Can Perspective Therapeutics Inc expand into new markets2026 Price Targets & Community Consensus Trade Alerts - baoquankhu1.vn
Trading Recap: What is the next catalyst for Perspective Therapeutics IncBull Run & Trade Opportunity Analysis - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Perspective Therapeutics, Inc. Experiences Evaluation Revision Amidst Mixed Market Signals - Markets Mojo
Avidity group holds 6.05M shares in CATX (NASDAQ: CATX) - Stock Titan
Jobs Data: Is Perspective Therapeutics Inc stock a hidden gemGap Down & Long-Term Safe Investment Ideas - baoquankhu1.vn
Aug Sentiment: Is Perspective Therapeutics Inc part of any ETF2026 Price Targets & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), ArriVent BioPharma, Inc. (AVBP) and Evommune, Inc. (EVMN) - The Globe and Mail
CATX SEC FilingsPerspective Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Perspective Therapeutics (CATX) director awarded 50,000-share stock option grant - Stock Titan
Director at Perspective Therapeutics (CATX) awarded 50,000 stock options - Stock Titan
Perspective Therapeutics Inc (CATX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):